A Research Agenda for DSM-V

Toward DSM-V: basic nomenclature issues. Proposed basic and clinical neuroscience research agenda to guide the development of a pathophysiologically-based classification. Report from developmental issues and diagnosis work group. A research agenda for addressing crucial gaps in the DSM: personality disorders and relational disorders. Mental disorders and disability: time to reevaluate the relationship? Beyond the funhouse mirrors: research agenda on culture and psychiatric diagnosis

[1]  H Fischer,et al.  Cerebral blood flow in subjects with social phobia during stressful speaking tasks: a PET study. , 2001, The American journal of psychiatry.

[2]  C. Pariante,et al.  Glial cell abnormalities in major psychiatric disorders: the evidence and implications , 2001, Brain Research Bulletin.

[3]  J. Cohen,et al.  Relation of prefrontal cortex dysfunction to working memory and symptoms in schizophrenia. , 2001, The American journal of psychiatry.

[4]  S. Faraone,et al.  Meta-analysis of the association between the 7-repeat allele of the dopamine D(4) receptor gene and attention deficit hyperactivity disorder. , 2001, The American journal of psychiatry.

[5]  A. Alavi,et al.  Effect of schizophrenia on frontotemporal activity during word encoding and recognition: a PET cerebral blood flow study. , 2001, The American journal of psychiatry.

[6]  M E Phelps,et al.  Regional brain metabolic changes in patients with major depression treated with either paroxetine or interpersonal therapy: preliminary findings. , 2001, Archives of general psychiatry.

[7]  J. Mill,et al.  Association study of a dopamine transporter polymorphism and attention deficit hyperactivity disorder in UK and Turkish samples , 2001, Molecular Psychiatry.

[8]  S. Houle,et al.  Changes in regional brain glucose metabolism measured with positron emission tomography after paroxetine treatment of major depression. , 2001, The American journal of psychiatry.

[9]  P. Renshaw,et al.  31P Nuclear magnetic resonance spectroscopy findings in bipolar illness: a meta-analysis , 2001, Psychiatry Research: Neuroimaging.

[10]  N. Andreasen,et al.  Comparison of the effects of risperidone and haloperidol on regional cerebral blood flow in schizophrenia , 2001, Biological Psychiatry.

[11]  R. McCarley,et al.  A review of MRI findings in schizophrenia , 2001, Schizophrenia Research.

[12]  C. Gillberg,et al.  Regional cerebral blood flow in weight‐restored anorexia nervosa: a preliminary study , 2001, Developmental medicine and child neurology.

[13]  K. Botteron,et al.  Family, genetic, and imaging studies of early-onset depression. , 2001, Child and adolescent psychiatric clinics of North America.

[14]  T L Faber,et al.  Neural activity related to drug craving in cocaine addiction. , 2001, Archives of general psychiatry.

[15]  O Almkvist,et al.  Impaired cerebral glucose metabolism and cognitive functioning predict deterioration in mild cognitive impairment , 2001, Neuroreport.

[16]  G. Alexander,et al.  Declining brain activity in cognitively normal apolipoprotein E ɛ4 heterozygotes: A foundation for using positron emission tomography to efficiently test treatments to prevent Alzheimer's disease , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[17]  B. Muthén.  Latent Variable Mixture Modeling , 2001 .

[18]  Cheuk Y. Tang,et al.  Patterns of cortical activity and memory performance in Alzheimer’s disease , 2001, Biological Psychiatry.

[19]  A. Chakravarti.  Single nucleotide polymorphisms: . . .to a future of genetic medicine , 2001, Nature.

[20]  Rebecca Elliott,et al.  fMRI and cognitive dysfunction in schizophrenia , 2001, Trends in Cognitive Sciences.

[21]  M. Baron,et al.  Genetics of schizophrenia and the new millennium: progress and pitfalls. , 2001, American journal of human genetics.

[22]  Yu-Shin Ding,et al.  Imaging brain cholinergic activity with positron emission tomography: its role in the evaluation of cholinergic treatments in Alzheimer’s dementia , 2001, Biological Psychiatry.

[23]  M F Weiner,et al.  SPECT imaging in dementias. , 2001, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[24]  J Blangero,et al.  Genetics of event-related brain potentials in response to a semantic priming paradigm in families with a history of alcoholism. , 2001, American journal of human genetics.

[25]  M. Stein.  Reactivity to a 35% CO2 challenge in healthy first-degree relatives of patients with panic disorder , 2000, Biological Psychiatry.

[26]  S. Joshi,et al.  Early DAT is distinguished from aging by high-dimensional mapping of the hippocampus , 2000, Neurology.

[27]  P. Rodier,et al.  Discovery of allelic variants of HOXA1 and HOXB1: genetic susceptibility to autism spectrum disorders. , 2000, Teratology.

[28]  J B Poline,et al.  Temporal lobe dysfunction in childhood autism: a PET study. Positron emission tomography. , 2000, The American journal of psychiatry.

[29]  Mark S. George,et al.  Regional cerebral metabolism associated with anxiety symptoms in affective disorder patients , 2000, Biological Psychiatry.

[30]  H Matsuda,et al.  Single-photon emission computed tomography of the brain in autism: effect of the developmental level. , 2000, Pediatric neurology.

[31]  T. Wienker,et al.  Splitting schizophrenia: periodic catatonia-susceptibility locus on chromosome 15q15. , 2000, American journal of human genetics.

[32]  D. Kupfer,et al.  Allelic Variation in the Serotonin Transporter Promoter Affects Onset of Paroxetine Treatment Response in Late-Life Depression , 2000, Neuropsychopharmacology.

[33]  G. Rajkowska,et al.  Postmortem studies in mood disorders indicate altered numbers of neurons and glial cells , 2000, Biological Psychiatry.

[34]  W. Drevets.  Neuroimaging studies of mood disorders , 2000, Biological Psychiatry.

[35]  R. Sapolsky,et al.  Glucocorticoids and hippocampal atrophy in neuropsychiatric disorders. , 2000, Archives of general psychiatry.

[36]  P. Sullivan,et al.  Genetic epidemiology of major depression: review and meta-analysis. , 2000, The American journal of psychiatry.

[37]  Pat Levitt,et al.  Molecular Characterization of Schizophrenia Viewed by Microarray Analysis of Gene Expression in Prefrontal Cortex , 2000, Neuron.

[38]  A. Bailey,et al.  Identifying Autism Susceptibility Genes , 2000, Neuron.

[39]  Deborah A Yurgelun-Todd,et al.  Neuroimaging in bipolar disorder: what have we learned? , 2000, Biological Psychiatry.

[40]  R S Judson,et al.  Complex promoter and coding region beta 2-adrenergic receptor haplotypes alter receptor expression and predict in vivo responsiveness. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[41]  S. Strakowski,et al.  Neuroimaging in bipolar disorder. , 2000, Bipolar disorders.

[42]  D. Pauls,et al.  Genetic aspects of obsessive-compulsive disorder. , 2000, The Psychiatric clinics of North America.

[43]  T. Uema,et al.  Abnormal regional cerebral blood flow in childhood autism. , 2000, Brain : a journal of neurology.

[44]  Matcheri S Keshavan,et al.  Magnetic resonance spectroscopy in schizophrenia: methodological issues and findings–part I , 2000, Biological Psychiatry.

[45]  V. Arango,et al.  A serotonin transporter gene promoter polymorphism (5-HTTLPR) and prefrontal cortical binding in major depression and suicide. , 2000, Archives of general psychiatry.

[46]  Ir W. De Backer,et al.  Review of neuroimaging studies of child and adolescent psychiatric disorders from the past 10 years. , 2000, Journal of the American Academy of Child and Adolescent Psychiatry.

[47]  P. Donnelly,et al.  Association mapping in structured populations. , 2000, American journal of human genetics.

[48]  D. Collier,et al.  Pharmacogenetic prediction of clozapine response , 2000, The Lancet.

[49]  K. Bucholz,et al.  Response to alcohol in daughters of alcoholics: a pilot study and a comparison with sons of alcoholics. , 2000, Alcohol and alcoholism.

[50]  S. Kapur,et al.  Relationship between dopamine D(2) occupancy, clinical response, and side effects: a double-blind PET study of first-episode schizophrenia. , 2000, The American journal of psychiatry.

[51]  N C Andreasen,et al.  Regional neural dysfunctions in chronic schizophrenia studied with positron emission tomography. , 2000, The American journal of psychiatry.

[52]  P. McGuffin,et al.  The genetics of major depressive disorder , 2000, Current psychiatry reports.

[53]  M. Schuckit.  Genetics of the risk for alcoholism. , 2000, The American journal on addictions.

[54]  M. Bucan,et al.  Dissection of behavior and psychiatric disorders using the mouse as a model. , 2000, Human molecular genetics.

[55]  A. Bailey,et al.  Autism: recent molecular genetic advances. , 2000, Human molecular genetics.

[56]  Stephen M. Mount,et al.  The genome sequence of Drosophila melanogaster. , 2000, Science.

[57]  P. McGuffin,et al.  Linkage and associated studies of schizophrenia. , 2000, American journal of medical genetics.

[58]  S. Faraone,et al.  Sustained attention deficits as markers of genetic susceptibility to schizophrenia. , 2000, American journal of medical genetics.

[59]  Marc Laruelle,et al.  The role of endogenous sensitization in the pathophysiology of schizophrenia: Implications from recent brain imaging studies , 2000, Brain Research Reviews.

[60]  F. Benes,et al.  Emerging principles of altered neural circuitry in schizophrenia , 2000, Brain Research Reviews.

[61]  J. Meador-Woodruff,et al.  Glutamate receptor expression in schizophrenic brain , 2000, Brain Research Reviews.

[62]  D. Collier,et al.  The serotonin transporter and clozapine response , 2000, Molecular Psychiatry.

[63]  S. Hodge,et al.  Potential panic disorder syndrome: clinical and genetic linkage evidence. , 2000, American journal of medical genetics.

[64]  M. Weissman,et al.  Selecting early onset MDD probands for genetic studies: results from a longitudinal high-risk study. , 2000, American journal of medical genetics.

[65]  Scott T. Grafton,et al.  Alterations in the functional anatomy of working memory in adult attention deficit hyperactivity disorder. , 2000, The American journal of psychiatry.

[66]  J. Callicott,et al.  The Relationship between Dorsolateral Prefrontal Neuronal N-Acetylaspartate and Evoked Release of Striatal Dopamine in Schizophrenia , 2000, Neuropsychopharmacology.

[67]  P A Sargent,et al.  Brain serotonin1A receptor binding measured by positron emission tomography with [11C]WAY-100635: effects of depression and antidepressant treatment. , 2000, Archives of general psychiatry.

[68]  D. Hamer,et al.  Beware the chopsticks gene , 2000, Molecular Psychiatry.

[69]  B. Carroll,et al.  Serotonin transporter gene polymorphism and antidepressant response , 2000, Neuroreport.

[70]  M. Ernst,et al.  Functional neuroimaging of autistic disorders. , 2000, Mental retardation and developmental disabilities research reviews.

[71]  A D Roses.  Pharmacogenetics and pharmacogenomics in the discovery and development of medicines. , 2000, Novartis Foundation symposium.

[72]  S. O’Rahilly,et al.  Dominant negative mutations in human PPARγ associated with severe insulin resistance, diabetes mellitus and hypertension , 1999, Nature.

[73]  J. Kelsoe.  Recent progress in the search for genes for bipolar disorder , 1999, Current psychiatry reports.

[74]  Huda Akil,et al.  Neural circuits mediating stress , 1999, Biological Psychiatry.

[75]  S. Alborzian,et al.  Localized Orbitofrontal and Subcortical Metabolic Changes and Predictors of Response to Paroxetine Treatment in Obsessive-Compulsive Disorder , 1999, Neuropsychopharmacology.

[76]  D. Kupfer,et al.  Pet imaging of serotonin 1A receptor binding in depression , 1999, Biological Psychiatry.

[77]  H. Sackeim,et al.  Serotonin, cerebral blood flow, and cerebral metabolic rate in geriatric major depression and normal aging , 1999, Brain Research Reviews.

[78]  R D Klausner,et al.  The mammalian gene collection. , 1999, Science.

[79]  S. Alborzian,et al.  Brain metabolic changes in major depressive disorder from pre- to post-treatment with paroxetine , 1999, Psychiatry Research: Neuroimaging.

[80]  H. Coon,et al.  Linkage of a composite inhibitory phenotype to a chromosome 22q locus in eight Utah families. , 1999, American journal of medical genetics.

[81]  Jay N Giedd,et al.  Childhood-onset schizophrenia: progressive brain changes during adolescence , 1999, Biological Psychiatry.

[82]  A. Sampson,et al.  Lamina-specific alterations in the dopamine innervation of the prefrontal cortex in schizophrenic subjects. , 1999, The American journal of psychiatry.

[83]  J. Soares,et al.  Neurochemical brain imaging investigations of schizophrenia , 1999, Biological Psychiatry.

[84]  J. Kleinman,et al.  Alterations of hippocampal secreted N-CAM in bipolar disorder and synaptophysin in schizophrenia , 1999, Molecular Psychiatry.

[85]  C R Cantor,et al.  Chip-based genotyping by mass spectrometry. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[86]  Kenneth K Kidd,et al.  Global variation in the frequencies of functionally different catechol-O-methyltransferase alleles , 1999, Biological Psychiatry.

[87]  N. Volkow,et al.  Imaging studies on the role of dopamine in cocaine reinforcement and addiction in humans , 1999, Journal of psychopharmacology.

[88]  G. Rajkowska,et al.  Brain Noradrenergic Receptors in Major Depression and Schizophrenia , 1999, Neuropsychopharmacology.

[89]  K. Bucholz,et al.  Common genetic vulnerability for nicotine and alcohol dependence in men. , 1999, Archives of general psychiatry.

[90]  W. Drevets.  Prefrontal Cortical‐Amygdalar Metabolism in Major Depression , 1999, Annals of the New York Academy of Sciences.

[91]  B. Roth,et al.  Morphometric evidence for neuronal and glial prefrontal cell pathology in major depression∗ ∗ See accompanying Editorial, in this issue. , 1999, Biological Psychiatry.

[92]  D. Dickstein,et al.  Topical Review: Functional Brain Imaging in Neuropsychiatric Disorders of Childhood , 1999, Journal of child neurology.

[93]  Israel Liberzon,et al.  Brain activation in PTSD in response to trauma-related stimuli , 1999, Biological Psychiatry.

[94]  M. Burmeister.  Basic concepts in the study of diseases with complex genetics , 1999, Biological Psychiatry.

[95]  F. Holsboer.  Animal models of mood disorders. , 1999 .

[96]  P. Filipek,et al.  Neuroimaging in the developmental disorders: the state of the science. , 1999, Journal of child psychology and psychiatry, and allied disciplines.

[97]  M. Ernst,et al.  Brain imaging studies of cocaine abuse: implications for medication development. , 1999, Critical reviews in neurobiology.

[98]  D S Cowley,et al.  Relationship between a GABAA alpha 6 Pro385Ser substitution and benzodiazepine sensitivity. , 1999, The American journal of psychiatry.

[99]  M. Reivich,et al.  Limbic activation during cue-induced cocaine craving. , 1999, The American journal of psychiatry.

[100]  G. MacQueen,et al.  Increased temporal cortex CREB concentrations and antidepressant treatment in major depression , 1998, The Lancet.

[101]  A. Bergen,et al.  General and specific inheritance of substance abuse and alcoholism. , 1998, Archives of general psychiatry.

[102]  E. Smeraldi,et al.  Polymorphism within the promoter of the serotonin transporter gene and antidepressant efficacy of fluvoxamine , 1998, Molecular Psychiatry.

[103]  K. Merikangas,et al.  Familial transmission of substance use disorders. , 1998, Archives of general psychiatry.

[104]  L. Bierut,et al.  Familial transmission of substance dependence: alcohol, marijuana, cocaine, and habitual smoking: a report from the Collaborative Study on the Genetics of Alcoholism. , 1998, Archives of general psychiatry.

[105]  J. Price,et al.  Glial reduction in the subgenual prefrontal cortex in mood disorders. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[106]  M Linnoila,et al.  Role of the serotonin transporter promoter polymorphism in anxiety-related traits. , 1998, Archives of general psychiatry.

[107]  Robert B Innis,et al.  Imaging of the serotonergic system: interactions of neuroanatomical and functional abnormalities of depression , 1998, Biological Psychiatry.

[108]  Christopher Gillberg,et al.  Chromosomal Disorders and Autism , 1998, Journal of autism and developmental disorders.

[109]  U. Grenander,et al.  Hippocampal morphometry in schizophrenia by high dimensional brain mapping. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[110]  J. Sludden,et al.  Ethnic differences in catechol O-methyltransferase pharmacogenetics: frequency of the codon 108/158 low activity allele is lower in Kenyan than Caucasian or South-west Asian individuals. , 1998, Pharmacogenetics.

[111]  David C. Steffens,et al.  Structural neuroimaging and mood disorders: Recent findings, implications for classification, and future directions , 1998, Biological Psychiatry.

[112]  J. Long,et al.  Evidence for genetic linkage to alcohol dependence on chromosomes 4 and 11 from an autosome-wide scan in an American Indian population. , 1998, American journal of medical genetics.

[113]  Stephen J. Guter,et al.  Linkage-disequilibrium mapping of autistic disorder, with 15q11-13 markers. , 1998, American journal of human genetics.

[114]  R. McCarley,et al.  323. Subgenual prefrontal cortex reduction in first episode affective psychosis , 1998, Biological Psychiatry.

[115]  S. Watson,et al.  Regulation of Serotonin1A, Glucocorticoid, and Mineralocorticoid Receptor in Rat and Human Hippocampus: Implications for the Neurobiology of Depression , 1998, Biological Psychiatry.

[116]  Á. Pazos,et al.  Selective Increase of α2A‐Adrenoceptor Agonist Binding Sites in Brains of Depressed Suicide Victims , 1998, Journal of neurochemistry.

[117]  J. Kleinman,et al.  Abnormal Expression of Cell Recognition Molecules in Schizophrenia , 1998, Experimental Neurology.

[118]  D. Kupfer,et al.  EEG sleep in African‐American patients with major depression: A historical case control study , 1998, Depression and anxiety.

[119]  Lars Farde,et al.  Brain imaging of schizophrenia—the dopamine hypothesis , 1997, Schizophrenia Research.

[120]  R. Saunders,et al.  A qualitative and quantitative analysis of the entorhinal cortex in schizophrenia. , 1997, Cerebral cortex.

[121]  W. Honer,et al.  Use of a quantitative trait to map a locus associated with severity of positive symptoms in familial schizophrenia to chromosome 6p. , 1997, American journal of human genetics.

[122]  Henry Kranzler,et al.  Serotonin transporter protein (SLC6A4) allele and haplotype frequencies and linkage disequilibria in African- and European-American and Japanese populations and in alcohol-dependent subjects , 1997, Human Genetics.

[123]  H. Meltzer,et al.  Reduced Levels of Norepinephrine Transporters in the Locus Coeruleus in Major Depression , 1997, The Journal of Neuroscience.

[124]  E. Nestler,et al.  A molecular and cellular theory of depression. , 1997, Archives of general psychiatry.

[125]  Christopher G. Davis,et al.  The familial aggregation of common psychiatric and substance use disorders in the National Comorbidity Survey: A family history study , 1997, British Journal of Psychiatry.

[126]  U. Grenander,et al.  Statistical methods in computational anatomy , 1997, Statistical methods in medical research.

[127]  J. Meador-Woodruff,et al.  Linking the Family of D2 Receptors to Neuronal Circuits in Human Brain: Insights into Schizophrenia , 1997, Neuropsychopharmacology.

[128]  C. Katona,et al.  Brain α-adrenoceptors in depressed suicides , 1997, Brain Research.

[129]  M. Raichle,et al.  Subgenual prefrontal cortex abnormalities in mood disorders , 1997, Nature.

[130]  R. Gur,et al.  Mesolimbic dopamine D3 receptors and use of antipsychotics in patients with schizophrenia. A postmortem study. , 1997, Archives of general psychiatry.

[131]  H. Meltzer,et al.  Serotonin Receptors in Suicide Victims with Major Depression , 1997, Neuropsychopharmacology.

[132]  L Kruglyak,et al.  Linkage of a neurophysiological deficit in schizophrenia to a chromosome 15 locus. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[133]  B Müller-Myhsok,et al.  Eye tracking dysfunction is a putative phenotypic susceptibility marker of schizophrenia and maps to a locus on chromosome 6p in families with multiple occurrence of the disease. , 1996, American journal of medical genetics.

[134]  J. Rapoport,et al.  Quantitative brain magnetic resonance imaging in attention-deficit hyperactivity disorder. , 1996, Archives of general psychiatry.

[135]  M F Glabus,et al.  Implications of Comorbidity for Genetic Studies of Bipolar Disorder: P300 and Eye Tracking as Biological Markers for Illness , 1996, British Journal of Psychiatry.

[136]  D. Botstein,et al.  A manic depressive history , 1996, Nature Genetics.

[137]  M S Buchsbaum,et al.  PET and MRI of the thalamus in never-medicated patients with schizophrenia. , 1996, The American journal of psychiatry.

[138]  M E Phelps,et al.  Systematic changes in cerebral glucose metabolic rate after successful behavior modification treatment of obsessive-compulsive disorder. , 1996, Archives of general psychiatry.

[139]  E. Lander,et al.  Genetic dissection of complex traits: guidelines for interpreting and reporting linkage results , 1995, Nature Genetics.

[140]  P. Goldman-Rakic,et al.  Abnormally high neuronal density in the schizophrenic cortex. A morphometric analysis of prefrontal area 9 and occipital area 17. , 1995, Archives of general psychiatry.

[141]  D F Swaab,et al.  Corticotropin-releasing hormone mRNA levels in the paraventricular nucleus of patients with Alzheimer's disease and depression. , 1995, The American journal of psychiatry.

[142]  J. Herman,et al.  Glucocorticoid Regulation of Stress‐Induced Mineralocorticoid Receptor Gene Transcription in Vivo , 1994, Annals of the New York Academy of Sciences.

[143]  D. Swaab,et al.  Increased numbers of corticotropin-releasing hormone expressing neurons in the hypothalamic paraventricular nucleus of depressed patients. , 1994, Neuroendocrinology.

[144]  Á. Pazos,et al.  Autoradiographic Demonstration of Increased α2‐Adrenoceptor Agonist Binding Sites in the Hippocampus and Frontal Cortex of Depressed Suicide Victims , 1994, Journal of neurochemistry.

[145]  C. Katona,et al.  Brain 5-HT2 receptors in suicide victims: violence of death, depression and effects of antidepressant treatment , 1994, Brain Research.

[146]  L. Erlenmeyer‐Kimling,et al.  Measuring liability to schizophrenia: progress report 1994: editors' introduction. , 1994, Schizophrenia bulletin.

[147]  M. Baron.  The D2 dopamine receptor gene and alcoholism: A tempest in a wine cup? , 1993, Biological Psychiatry.

[148]  K. Davis,et al.  Selective loss of dopamine D3-type receptor mRNA expression in parietal and motor cortices of patients with chronic schizophrenia. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[149]  M. Palkovits,et al.  5-HT uptake sites and 5-HT2 receptors in brain of antidepressant-free suicide victims/depressives: increase in 5-HT2 sites in cortex and amygdala , 1993, Brain Research.

[150]  An evaluation of the structure of schizophrenia spectrum personality disorders , 1994 .

[151]  C A Sandman,et al.  Altered distribution of nicotinamide-adenine dinucleotide phosphate-diaphorase cells in frontal lobe of schizophrenics implies disturbances of cortical development. , 1993, Archives of general psychiatry.

[152]  D. Neary,et al.  Antemortem measurements of neurotransmission: possible implications for pharmacotherapy of Alzheimer's disease and depression. , 1993, Journal of neurology, neurosurgery, and psychiatry.

[153]  J. Mazziotta,et al.  Caudate glucose metabolic rate changes with both drug and behavior therapy for obsessive-compulsive disorder. , 1992, Archives of general psychiatry.

[154]  J. García-Sevilla,et al.  α 2-Adrenoceptors in the brain of suicide victims: increased receptor density associated with major depression , 1992, Biological Psychiatry.

[155]  H. Akil,et al.  Localization and quantification of pro-opiomelanocortin mRNA and glucocorticoid receptor mRNA in pituitaries of suicide victims. , 1992, Neuroendocrinology.

[156]  F. Benes,et al.  Reduced neuronal size in posterior hippocampus of schizophrenic patients. , 1991, Schizophrenia bulletin.

[157]  V. Arango,et al.  Autoradiographic demonstration of increased serotonin 5-HT2 and beta-adrenergic receptor binding sites in the brain of suicide victims. , 1990, Archives of general psychiatry.

[158]  B. Pakkenberg,et al.  Pronounced reduction of total neuron number in mediodorsal thalamic nucleus and nucleus accumbens in schizophrenics. , 1990, Archives of general psychiatry.

[159]  I. Ferrier,et al.  5HT2 receptor changes in major depression , 1990, Biological Psychiatry.

[160]  Anat Biegon,et al.  Autoradiographic analysis of [3H]ketanserin binding in the human brain postmortem: effect of suicide , 1990, Brain Research.

[161]  P. Francis,et al.  Circumscribed changes of the cerebral cortex in neuropsychiatric disorders of later life. , 1989, Proceedings of the National Academy of Sciences of the United States of America.

[162]  H. Meltzer,et al.  Increased serotonin2 (5-HT2) receptor binding as measured by 3H-lysergic acid diethylamide (3H-LSD) in the blood platelets of depressed patients. , 1989, Life sciences.

[163]  M. Casanova,et al.  Is there a neuropathology of schizophrenia? , 1988, Biological Psychiatry.

[164]  C. Nemeroff,et al.  Reduced corticotropin releasing factor binding sites in the frontal cortex of suicide victims. , 1988, Archives of general psychiatry.

[165]  C. Katona,et al.  Brain 5-HT2 receptor binding sites in depressed suicide victims , 1988, Brain Research.

[166]  A. Zis,et al.  Increased adrenal weight in victims of violent suicide. , 1987, The American journal of psychiatry.

[167]  E. Perry,et al.  5-HT receptor binding in post-mortem brain from patients with affective disorder. , 1987, Journal of affective disorders.

[168]  D. Mccormick.  Sequence the Human Genome , 1986, Bio/Technology.

[169]  B. McEwen,et al.  Increased serotonin2 and beta-adrenergic receptor binding in the frontal cortices of suicide victims. , 1986, Archives of general psychiatry.

[170]  T. Crow,et al.  Serotonergic mechanisms in brains of suicide victims , 1986, Brain Research.

[171]  T. Crow,et al.  Neurotransmitter receptors and monoamine metabolites in the brains of patients with Alzheimer-type dementia and depression, and suicides , 1984, Neuropharmacology.

[172]  E. Perry,et al.  Decreased Imipramine Binding in the Brains of Patients with Depressive Illness , 1983, British Journal of Psychiatry.

[173]  J. Mann,et al.  INCREASED SEROTONIN-2 BINDING SITES IN FRONTAL CORTEX OF SUICIDE VICTIMS , 1983, The Lancet.